| Patent | Date |
|---|
AXL kinase inhibitors and use of the same
Grant 11,400,091 - Siddiqui-Jain , et al. August 2, 2 | 2022-08-02 |
Pkm2 Modulators And Methods For Their Use
App 20220162200 - Siddiqui-Jain; Adam | 2022-05-26 |
Alvocidib prodrugs and their use as protein kinase inhibitors
Grant 11,279,694 - Siddiqui-Jain , et al. March 22, 2 | 2022-03-22 |
Antimitotic Amides For The Treatment Of Cancer And Proliferative Disorders
App 20220008395 - SIDDIQUI-JAIN; Adam | 2022-01-13 |
CDK9 Inhibitors and Polymorphs Thereof For Use As Agents For Treatment of Cancer
App 20210332071 - Siddiqui-Jain; Adam ; et al. | 2021-10-28 |
Antimitotic amides for the treatment of cancer and proliferative disorders
Grant 11,129,813 - Siddiqui-Jain September 28, 2 | 2021-09-28 |
Deuterated Alvocidib And Alvocidib Prodrugs
App 20210277037 - SIDDIQUI-JAIN; Adam | 2021-09-09 |
Alvocidib Prodrugs Having Increased Bioavailability
App 20210261585 - Siddiqui-Jain; Adam ; et al. | 2021-08-26 |
Combination Therapies For Treatment Of Cancer
App 20210228582 - Bearss; David J. ; et al. | 2021-07-29 |
Axl Kinase Inhibitors And Use Of The Same
App 20210205304 - Siddiqui-Jain; Adam ; et al. | 2021-07-08 |
Methods for treating diseases associated with abnormal ACVR1 expression and ACVR1 inhibitors for use in the same
Grant 11,040,038 - Warner , et al. June 22, 2 | 2021-06-22 |
CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancer
Grant 11,034,710 - Siddiqui-Jain , et al. June 15, 2 | 2021-06-15 |
AXL kinase inhibitors and use of the same
Grant 11,013,741 - Siddiqui-Jain , et al. May 25, 2 | 2021-05-25 |
AXL kinase inhibitors and use of the same
Grant 10,888,562 - Siddiqui-Jain , et al. January 12, 2 | 2021-01-12 |
Tyrosine Kinase Non-Receptor 1 (TNK1) Inhibitors and Uses Thereof
App 20210000825 - Siddiqui-Jain; Adam ; et al. | 2021-01-07 |
Antimitotic Amides for the Treatment of Cancer and Proliferative Disorders
App 20200397758 - SIDDIQUI-JAIN; Adam | 2020-12-24 |
Combination therapies for treatment of cancer
Grant 10,835,537 - Bearss , et al. November 17, 2 | 2020-11-17 |
Formulations Comprising Heterocyclic Protein Kinase Inhibitors
App 20200338076 - WARNER; Steven L. ; et al. | 2020-10-29 |
Antimitotic amides for the treatment of cancer and proliferative disorders
Grant 10,772,872 - Siddiqui-Jain Sept | 2020-09-15 |
Treatment Regimen For Cancers That Are Insensitive To Bcl-2 Inhibitors Using The Mcl-1 Inhibitor Alvocidib
App 20200276215 - BEARSS; David J. ; et al. | 2020-09-03 |
Cdk9 Inhibitors And Polymorphs Thereof For Use As Agents For Treatment Of Cancer
App 20200255462 - Kind Code | 2020-08-13 |
Pkm2 Activators In Combination With Reactive Oxygen Species For Treatment Of Cancer
App 20200237766 - SIDDIQUI-JAIN; Adam ; et al. | 2020-07-30 |
Combination Therapies For Treatment Of Cancer
App 20200215071 - Bearss; David J. ; et al. | 2020-07-09 |
Profiling Peptides And Methods For Sensitivity Profiling
App 20200200737 - BEARSS; David J. ; et al. | 2020-06-25 |
Combination therapies for treatment of cancer
Grant 10,682,356 - Bearss , et al. | 2020-06-16 |
Alvocidib Prodrugs Having Increased Bioavailability
App 20200131210 - Siddiqui-Jain; Adam ; et al. | 2020-04-30 |
Methods For Treating Diseases Associated With Abnormal Acvr1 Expression And Acvr1 Inhibitors For Use In The Same
App 20200085823 - Warner; Steven L. ; et al. | 2020-03-19 |
Combination therapies for treatment of cancer
Grant 10,568,887 - Bearss , et al. Feb | 2020-02-25 |
Combination Therapies For Treatment Of Cancer
App 20200054642 - Bearss; David J. ; et al. | 2020-02-20 |
Alvocidib prodrugs having increased bioavailability
Grant 10,562,925 - Siddiqui-Jain , et al. Feb | 2020-02-18 |
Alvocidib Prodrugs And Their Use As Protein Kinase Inhibitors
App 20200048228 - Siddiqui-Jain; Adam ; et al. | 2020-02-13 |
Profiling peptides and methods for sensitivity profiling
Grant 10,422,788 - Bearss , et al. Sept | 2019-09-24 |
Alvocidib Prodrugs Having Increased Bioavailability
App 20190177350 - Siddiqui-Jain; Adam ; et al. | 2019-06-13 |
Profiling Peptides And Methods For Sensitivity Profiling
App 20190178873 - BEARSS; David J. ; et al. | 2019-06-13 |
Profiling peptides and methods for sensitivity profiling
Grant 10,267,787 - Bearss , et al. | 2019-04-23 |
Alvocidib prodrugs having increased bioavailability
Grant 10,259,835 - Siddiqui-Jain , et al. | 2019-04-16 |
Profiling peptides and methods for sensitivity profiling
Grant 10,132,797 - Bearss , et al. November 20, 2 | 2018-11-20 |
Antimitotic Amides For The Treatment Of Cancer And Proliferative Disorders
App 20180325871 - Siddiqui-Jain; Adam | 2018-11-15 |
Profiling Peptides And Methods For Sensitivity Profiling
App 20180299432 - Bearss; David J. ; et al. | 2018-10-18 |
Combination Therapies For Treatment Of Cancer
App 20180256580 - Bearss; David J. ; et al. | 2018-09-13 |
Antimitotic amides for the treatment of cancer and proliferative disorders
Grant 10,016,398 - Siddiqui-Jain July 10, 2 | 2018-07-10 |
Profiling Peptides And Methods For Sensitivity Profiling
App 20180172673 - Bearss; David J. ; et al. | 2018-06-21 |
Alvocidib Prodrugs Having Increased Bioavailability
App 20170334938 - Siddiqui-Jain; Adam ; et al. | 2017-11-23 |
Alvocidib prodrugs having increased bioavailability
Grant 9,758,539 - Siddiqui-Jain , et al. September 12, 2 | 2017-09-12 |
Antimitotic Amides For The Treatment Of Cancer And Proliferative Disorders
App 20170172984 - SIDDIQUI-JAIN; Adam | 2017-06-22 |
Alvocidib Prodrugs Having Increased Bioavailability
App 20160340376 - Siddiqui-Jain; Adam ; et al. | 2016-11-24 |
Substituted Quinobenzoxazine Analogs
App 20120122804 - Whitten; Jeffrey P. ; et al. | 2012-05-17 |
Methods For Targeting Quadruplex Sequences
App 20090291437 - O'Brien; Sean ; et al. | 2009-11-26 |
Substituted quinobenzoxazine analogs
Grant 7,612,063 - Whitten , et al. November 3, 2 | 2009-11-03 |
HUMAN RIBOSOMAL DNA (rDNA) AND RIBOSOMAL RNA (rRNA) NUCLEIC ACIDS AND USES THEREOF
App 20090181377 - Drygin; Denis ; et al. | 2009-07-16 |
Substituted quinobenzoxazine analogs and methods of using thereof
Grant 7,507,727 - Whitten , et al. March 24, 2 | 2009-03-24 |
Substituted Quinobenzoxazine Analogs
App 20080261963 - Whitten; Jeffrey P. ; et al. | 2008-10-23 |
Methods for regulating transcription by targeting quadruplex DNA
Grant 7,405,041 - Ebbinghaus , et al. July 29, 2 | 2008-07-29 |
Substituted quinobenzoxazine analogs
Grant 7,381,720 - Whitten , et al. June 3, 2 | 2008-06-03 |
Substituted quinobenzoxazine analogs
Grant 7,354,916 - Whitten , et al. April 8, 2 | 2008-04-08 |
Competition Assay for Identifying Modulators of Quadruplex Nucleic Acids
App 20080032286 - Siddiqui-Jain; Adam ; et al. | 2008-02-07 |
Substituted quinobenzoxazine analogs
Grant 7,326,702 - Whitten , et al. February 5, 2 | 2008-02-05 |
Human ribosomal DNA (rDNA) and ribosomal RNA (rRNA) nucleic acids and uses thereof
App 20070117770 - Drygin; Denis ; et al. | 2007-05-24 |
Substituted quinobenzoxazine analogs
App 20070043039 - Whitten; Jeffrey P. ; et al. | 2007-02-22 |
MCL-1 quadruplex nucleic acids and uses thereof
App 20060286575 - Farrell; Thomas J. ; et al. | 2006-12-21 |
MAX quadruplex nucleic acids and uses thereof
App 20060281115 - Siddiqui-Jain; Adam | 2006-12-14 |
Substituted quinobenzoxazine analogs
Grant 7,141,565 - Whitten , et al. November 28, 2 | 2006-11-28 |
Substituted quinobenzoxazine analogs
App 20060229303 - Whitten; Jeffrey P. ; et al. | 2006-10-12 |
Processes for identifying quadruplex-targeted antiviral molecules
App 20060183106 - Siddiqui-Jain; Adam | 2006-08-17 |
Substituted quinobenzoxazine analogs and methods of using thereof
App 20060029950 - Whitten; Jeffrey P. ; et al. | 2006-02-09 |
Substituted quinobenzoxazine analogs
App 20050085468 - Whitten, Jeffrey P. ; et al. | 2005-04-21 |
Methods for regulating transcription by targeting quadruplex DNA
App 20040171022 - Ebbinghaus, Scot W. ; et al. | 2004-09-02 |
High-throughput methods for identifying quadruplex forming nucleic acids and modulators thereof
App 20040115706 - Jin, Cheng He ; et al. | 2004-06-17 |
Methods for targeting quadruplex DNA
App 20040005601 - Siddiqui-Jain, Adam ; et al. | 2004-01-08 |
| 